Skip to main content
. Author manuscript; available in PMC: 2010 Jul 14.
Published in final edited form as: Transplant Proc. 1990 Feb;22(1):25–34.

Table 4.

Biopsy Pathology Diagnosis In Specimens Obtained During First Month From Patients Treated From the Outset With FK 506 Versus Historic Controls Treated With CyA

Primary FK 506
Controls
Patient Pathology Diagnosis (Days posttransplant) Patient Pathology Diagnosis (Days posttransplant)
A.D. Mild focal ACR (11) T.F. Moderate ACR (4, 13)
C.A. Portal reactive change (14) G.K. FG, arterial thrombosis (14)
D.B. Portal reactive change (12) L.K. Mild ACR (10)
I.C. Mild ACR (6); Moderate ACR, cholangitis (13); severe ACR (27) L.K. Mild ACR (9)
J.C. Minimal portal eosinophilia (8) H.S. Moderate preservation injury (4)
D.F. Portal reactive change (11) B.Z. Mild preservation injury (5)
G.G. Portal reactive change (8) J.H. Mild ACR (11)
T.H. Mild ACR (3), mild ongoing ACR (14) W.E. Moderate ACR (7)
N.H. NSC (3, 11) S.C. NA
S.K. Mild portal eosinophilia (10) L.C. NA
S.M. Portal reactive change (8) L.D. Mild ACR (30)
S.M. Mild ACR (10) M.M. NA
A.M. Mild ACR (11) Z.G. Moderate ACR (9)
D.M.* Portal reactive change (14) H.I. FG, arterial thrombosis, mild-moderate ACR (4)
S.R. NSC (11) C.K. NA
D.R. Mild preservation injury (6, 10) D.H. Moderate ACR (11)
J.S. NA J.G. Mild ACR, partially treated (9)
H.S. Mild ACR (7) M.T. Moderate ACR (10)
M.S. Mild steatosis (13) E.M. Moderate ACR (20)
K.W. Mild preservation injury (12) B.E. Severe preservation injury (12)

Abbreviations: ACR, acute cellular rejection; FG, failed graft; NA not available; NSC, nonspecific changes.

*

Patient died.